2025년 실제 재무 비교
Regeneron Pharmaceuticals, Inc. - Common Stock 대 Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock 재무 비교
Regeneron Pharmaceuticals, Inc. - Common Stock 대 Northern Trust Corporation - D…
바로 답
4개 공통 지표를 같은 USD 기준으로 비교합니다.
Regeneron Pharmaceuticals, Inc. - Common Stock의 매출은 14,342,900,000 USD입니다.
Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock의 같은 지표는 14,299,900,000 USD입니다.
Alpha Vantage의 같은 회계연도 자료를 사용했습니다.
확인된 데이터입니다.
- Regeneron Pharmaceuticals, Inc. - Common Stock 매출
- 14,342,900,000 USD
- Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock 매출
- 14,299,900,000 USD
- Regeneron Pharmaceuticals, Inc. - Common Stock 영업이익
- 3,577,900,000 USD
- Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock 영업이익
- 2,331,500,000 USD
- Regeneron Pharmaceuticals, Inc. - Common Stock 순이익
- 4,504,900,000 USD
- Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock 순이익
- 1,736,900,000 USD
- Regeneron Pharmaceuticals, Inc. - Common Stock 영업현금흐름
- 4,978,900,000 USD
- Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock 영업현금흐름
- 5,533,500,000 USD
관련 기업 자료를 이어서 확인합니다.
Regeneron Pharmaceuticals, Inc. - Common Stock 전체 동종 기업 비교를 확인합니다.Regeneron Pharmaceuticals, Inc. - Common Stock 종합 기업 정보로 이동합니다.Northern Trust Corporation - Depositary Shares Each Representing a 1/1,000th Interest in a Share of Series E Non-Cumulative Perpetual Preferred Stock 종합 기업 정보로 이동합니다.Regeneron Pharmaceuticals, Inc. - Common Stock 2025년 전체 재무를 확인합니다.